Comparison of Scalp Microbiome of Healthy Women Wearing Hijab and Those Who do Not Wear Hijab
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The scalp sample of all subjects was taken to be analyzed for its microbial diversity. The samples were processed with Next-Generation Sequencer and analyzed with bioinformatics analysis.
The primary outcome was the characteristics of scalp microbiome
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Jakarta, Indonesia, 10430
- Faculty of Medicine, Universitas Indonesia
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy women
- Aged 18 years old or older who had not undergone menopause
- Consenting to the study
Exclusion Criteria:
- Scalp and hair diseases (e.g. alopecia, trichotillomania, scalp infection, malignancy)
- Systemic diseases (diabetes mellitus, liver diseases, renal diseases, autoimmune diseases)
- Use of topical and oral antifungal agents
- Use of cytostatic agents
- Use of topical and oral antibiotics
- Use of topical and oral vitamin D
- Use of chemical products on hair (e.g. bleaching, permanent blow, hair coloring, hair straightener)
- Pregnancy
- Lactating
- Hypersensitivity towards basic ingredients of shampoo (e.g. synthetic detergent, conditioner, thickening agent).
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Hijab
Women wearing hijab whose scalp sample was taken for microbiome analysis
|
The scalp was swabbed with five strokes which were performed each in a vertical, horizontal, left diagonal, and right diagonal direction.
The swab was moved back and forth for 10 times
|
|
No hijab
Women not wearing hijab whose scalp sample was taken for microbiome analysis
|
The scalp was swabbed with five strokes which were performed each in a vertical, horizontal, left diagonal, and right diagonal direction.
The swab was moved back and forth for 10 times
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Alpha diversity and beta diversity of scalp microbiome
Time Frame: Up to 2 years
|
The alpha and beta diversity of scalp microbiome which is generated by bioinformatics analysis from the sample processed with Next-Generation Sequencing
|
Up to 2 years
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 19-04-0438
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.